Serapha Bio
Serapha Bio
seraphabio.com
Locations
San Diego, CA, USA
About

Serapha Bio is a clinical-stage genetic medicines company developing a proprietary base editing therapy, SERP-01, for patients with alpha-1 antitrypsin deficiency (AATD), the leading genetic cause of serious, progressive lung and liver disease. SERP-01 is in clinical development for the treatment of AATD patients with the PiZZ genotype, the most severe genetic mutation responsible for >90% of AATD cases. SERP-01 consists of a lipid nanoparticle formulation containing messenger RNA encoding Serapha’s proprietary adenine base editor together with a guide RNA. The therapy is designed to enable precise correction of the disease-causing mutation in PiZZ AATD. Correcting PiZZ, the most common gene variant associated with severe AATD, could address a large population in the U.S. and Europe.

Something looks off?
Open jobs at Serapha Bio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.